Health systems around the US are on the cusp of receiving COVID-19 vaccines. At the end of this months-long effort are the nitty-gritty details of how health care providers are giving people the vaccine.
Academic rigor, journalistic flair
Articles on Coronavirus vaccines
Displaying 81 - 100 of 125 articles
Reports of two UK health workers having allergic reactions after receiving Pfizer’s COVID vaccine have led to safety warnings for others at risk of anaphylaxis.
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
It may be many months before COVID control measures can be eased.
Here’s why we could reduce the period for self-isolation.
Asking these four questions can help us identify good news when we see it, be more critical of news reports, or delay our judgement until we have more information.
Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Biden will begin his presidency in the midst of a global public health crisis that’s already killed over 240,000 people in the US alone. His team is already planning how to get COVID-19 under control.
The world leader in generic medicines is facing stiff competition.
People who oppose vaccines often are dismissed as ignorant or naive. Failing to hear their concerns and address them may only be fueling vaccine resistance, however.
Focusing on the coronavirus vaccine is a useful way for China to squeeze out room for more difficult questions about its initial response to COVID-19.
Medical innovation is often accelerated in a time of crisis.
A sports management scholar weighs in on the potential consequences of holding Big Ten football games in the fall instead of waiting for a vaccine or better safety procedures.
From adenoviruses to RNA: the pros and cons of different COVID vaccine technologies
A tragic error showed how complicated it can be to distribute vaccines on a mass scale.
Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won’t happen unless people believe it’s safe.
Another day, another politicised vaccine.
A primer on Sinovac, Sinopharm and CanSino, and their prospects for achieving a world first for coronavirus.
Church leaders have raised concerns over a COVID-19 vaccine produced using cells derived from aborted foetuses. But the Vatican has already ruled such vaccines ‘morally separate’ from the abortions.
Thousands of people around the world have said they are willing to be exposed to COVID-19 to test new vaccines. Since we don’t fully understand the long-term effects of the disease, is this ethical?
Top contributors
-
Professorial Fellow, University of Canberra
-
Professor of Medicine, University of East Anglia
-
FAPESP-Postdoctoral Researcher at the Laboratory of Structural Biology and Zoochemistry, IB/RC (UNESP), University of São Paulo State
-
Professor of Economics, University of Birmingham
-
Associate Professor of Biology, Rochester Institute of Technology
-
Senior Lecturer in Biochemistry and Cell Biology, University College Cork
-
Associate professor, UNSW Sydney
-
Senior Research Fellow in Global Health, University of Southampton
-
Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine
-
Associate Professor of Marketing, University of Technology Sydney
-
Professor, Languages, Literatures and Cultures, Queen's University, Ontario
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Assistant Professor of Political Science, Oklahoma State University
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor of Economics, University of Maryland
